Why Novo Nordisk’s CEO has learned to trust his gut feeling
May 28, 2024
49:08
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
Lars Fruergaard Jørgensen, CEO of the company which makes game-changing obesity drugs Ozempic and Wegovy, explains how its culture and long-view underpin its recent turnaround.
